Thus, the reduction of G0S2 expression observed in CML CD34+ cells (Figure 1A) is due to GMPs, the disease‐causing population in BP‐CML.62 The gene discussed is G0S2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.